Brachyspira hyodysenteriae (Swine Dysentery): A Comprehensive Veterinary Reference
By Dr. Zubair Khalid, DVM, MS, PhD ·
Key Takeaways
- Brachyspira hyodysenteriae is a Gram-negative, anaerobic spirochete causing mucohemorrhagic colitis in pigs, characterized by bloody diarrhea and significant economic losses. Transmission is primarily fecal-oral, with environmental persistence in slurry and mechanical dissemination by insects like houseflies.
- Pathogenesis involves attachment to the colonic mucosa, disruption of epithelial integrity via hemolysin production, and induction of a pro-inflammatory response that impairs ion transport and contributes to secretory diarrhea. Altered mucin dynamics facilitate deeper tissue penetration.
- Definitive diagnosis relies on laboratory confirmation via anaerobic culture (showing β-hemolysis and indole positivity) or highly sensitive real-time PCR (qPCR) targeting the nox gene, with oral fluids being a practical matrix for herd-level surveillance.
- Antimicrobial resistance is a growing concern, with increasing minimum inhibitory concentrations (MICs) reported for pleuromutilins and macrolides; multidrug-resistant strains are identified in several regions.
- Eradication is achievable through integrated strategies including depopulation-repopulation, management-based protocols with antimicrobials (e.g., zinc chelate), strict biosecurity, and rodent control. Non-antibiotic alternatives like competitive exclusion probiotics are under investigation.
- Gut microbiota dysbiosis, particularly reduced Lactobacillus and Prevotella abundance, predisposes pigs to colonization, and infection further disrupts microbial diversity, correlating with disease severity. Co-infection with Lawsonia intracellularis can exacerbate clinical signs.
Introduction
Brachyspira hyodysenteriae is a Gram-negative, anaerobic, spirochete bacterium that is the primary etiological agent of swine dysentery (SD), a globally significant mucohemorrhagic colitis of growing pigs [<a href="#ref-1">1</a>, <a href="#ref-2">2</a>]. The disease is characterized by severe inflammation of the large intestine, leading to bloody, mucoid diarrhea, reduced weight gain, and substantial economic losses in affected herds [<a href="#ref-3">3</a>, <a href="#ref-4">4</a>]. B. hyodysenteriae colonizes the colonic and cecal crypts, where it disrupts epithelial integrity through a combination of motility, hemolysin production, and host immune subversion [<a href="#ref-5">5</a>, <a href="#ref-6">6</a>]. This review integrates the latest peer-reviewed literature (2022-2026) on the pathogen's genomic architecture, metabolomic signatures, diagnostic advances, antimicrobial susceptibility patterns, microbiome interactions, and eradication strategies.
Taxonomy and Phylogeny
B. hyodysenteriae belongs to the phylum Spirochaetes, family Brachyspiraceae. Historically classified as Treponema hyodysenteriae, it was reclassified into the genus Brachyspira based on 16S rRNA gene sequence analysis [<a href="#ref-7">7</a>]. Whole-genome sequencing has revealed a core genome of approximately 3.1 Mb with a low G+C content (approximately 27 mol%) [<a href="#ref-8">8</a>]. Multilocus sequence typing (MLST) has identified numerous sequence types (STs) circulating globally, with ST245 being capable of colonizing asymptomatic pigs [<a href="#ref-9">9</a>]. Genomic studies have demonstrated a highly plastic, recombinogenic population structure, with extensive exchange of antimicrobial resistance (AMR) genes and virulence determinants across geographical regions [<a href="#ref-10">10</a>]. Rohde et al. (2025) published complete genome sequences of reference strains B204 and JR80, providing essential resources for comparative genomics and functional studies [<a href="#ref-8">8</a>].
Epidemiology and Transmission
Swine dysentery is transmitted predominantly via the fecal, oral route. Excretion of B. hyodysenteriae in feces begins approximately 4-7 days post-infection and can persist for weeks, even in subclinically infected animals [<a href="#ref-11">11</a>]. Environmental persistence is facilitated by the bacterium's ability to survive in slurry for at least 60 days. Common insect vectors, including houseflies (Musca domestica), have been shown to mechanically carry viable B. hyodysenteriae, contributing to within-herd and between-herd dissemination [<a href="#ref-12">12</a>]. In a multi-country European prevalence study, Arnold et al. (2023) reported that 18-45% of pig herds with a history of diarrhea harbored Brachyspira spp., with B. hyodysenteriae the most frequently diagnosed species [<a href="#ref-13">13</a>]. Risk factors include continuous flow production, contaminated transport vehicles, and lack of biosecurity measures. Sweden has achieved national-level control of SD through a combination of surveillance, depopulation-repopulation, and strict movement restrictions, demonstrating the feasibility of eradication at a national scale [<a href="#ref-14">14</a>].
Pathogenesis and Virulence Mechanisms
The pathogenic cascade of B. hyodysenteriae begins with attachment to the colonic mucosa, mediated by specific adhesion factors that recognize porcine intestinal glycosphingolipids [<a href="#ref-15">15</a>]. Once established in the crypt lumen, the spirochetes proliferate and produce β-hemolysin (hlyA) and other cytotoxins that damage colonic epithelial cells [<a href="#ref-16">16</a>]. A hallmark of SD is the induction of a robust innate immune response. Transcriptomic profiling of colonic mucosa during acute infection reveals upregulation of pro-inflammatory cytokines (IL-1α, IL-6, TNF-α) and chemokines, coupled with downregulation of ion transporters such as DRA (SLC26A3) [<a href="#ref-17">17</a>]. The decreased DRA expression, driven by a p38-dependent IL-1α response, impairs Cl⁻/HCO₃⁻ exchange, contributing directly to secretory diarrhea [<a href="#ref-17">17</a>]. Concurrently, infection alters mucin dynamics: acute SD reduces expression of gel-forming mucins (MUC2, MUC5AC) and modifies glycosylation patterns in the colonic mucus layer, facilitating deeper tissue penetration [<a href="#ref-18">18</a>].
Metabolomic analysis of colonic tissues from infected pigs reveals distinct shifts in amino acid, lipid, and energy metabolism, reflecting the host's metabolic reprogramming in response to infection [<a href="#ref-1">1</a>]. Acute infection also correlates with changes in fecal MUC5AC levels, which may serve as a non-invasive biomarker for early-stage SD [<a href="#ref-11">11</a>, <a href="#ref-18">18</a>].
Microbiome Interactions and Co-infections
The colonic microbiota plays a critical role in susceptibility and pathogenesis. Field studies have shown that pre-existing dysbiosis, specifically reduced abundance of Lactobacillus and Prevotella spp., predisposes pigs to colonization by B. hyodysenteriae [<a href="#ref-3">3</a>]. Following infection, the microbiota undergoes further disruption: alpha diversity decreases, and the relative abundance of pathogenic Escherichia and Clostridium groups increases [<a href="#ref-7">7</a>]. These microbiome shifts correlate with the severity of colitis, as assessed by histopathological scoring [<a href="#ref-7">7</a>].
Co-infection with Lawsonia intracellularis, the agent of porcine proliferative enteropathy, is common in field settings and can exacerbate clinical disease. Experimental dual infections result in more severe lesions and compounded dysbiosis compared with single-agent challenges [<a href="#ref-19">19</a>]. Conversely, vaccination against L. intracellularis does not appear to interfere with B. hyodysenteriae colonization or immune responses, though co-infected pigs may show altered fecal shedding patterns [<a href="#ref-6">6</a>].
Clinical Signs and Pathology
The incubation period ranges from 7 to 21 days. Clinical signs begin with yellowish, soft feces that progress to watery, mucoid diarrhea containing flecks of fresh blood. In peracute cases, pigs may die without prodromal signs. Morbidity is high (up to 90%), but mortality is typically low (5-10%) unless complicated by other enteric pathogens or management stress [<a href="#ref-11">11</a>]. Growth performance is severely compromised; digestibility of dietary fiber is reduced, and feed conversion ratio increases significantly.
Gross pathology is confined to the large intestine. The cecal and colonic walls are edematous, congested, and covered with a fibrino-mucoid exudate. The mucosa appears hyperemic, and the contents are mucohemorrhagic. Histologically, lesions include goblet cell hyperplasia, erosion of surface epithelium, crypt elongation, and a mixed inflammatory infiltrate (neutrophils, macrophages) [<a href="#ref-16">16</a>]. Colonic innate immune defenses, such as antimicrobial peptide expression, are overwhelmed during acute disease, allowing spirochetes to invade deeper crypt regions [<a href="#ref-16">16</a>].
Diagnostic Approaches
Clinical and Pathological Diagnosis
Presumptive diagnosis is based on compatible clinical signs and gross lesions. However, definitive diagnosis requires laboratory confirmation due to overlapping presentations with Salmonella spp., Lawsonia intracellularis, and Brachyspira pilosicoli.
Bacteriological Culture and Isolation
Anaerobic culture on selective media (e.g., trypticase soy agar with 5% sheep blood and spectinomycin, vancomycin, colistin) remains a reference method. B. hyodysenteriae produces a strong β-hemolysis zone (typically 5-10 mm) and is indole-positive, features that differentiate it from other porcine Brachyspira species [<a href="#ref-9">9</a>]. Nonetheless, culture is slow (3-7 days) and lacks sensitivity for subclinical carriers.
Nucleic Acid Detection
Real-time PCR (qPCR) assays targeting the nox gene or 16S rRNA gene are now standard due to their high sensitivity and specificity. Multiplex qPCR formats enable simultaneous detection of B. hyodysenteriae with other important swine pathogens.
- Wu et al. (2025) developed a triplex real-time PCR for B. hyodysenteriae, L. intracellularis, and Clostridium perfringens [<a href="#ref-20">20</a>].
- Wang et al. (2024) validated a quadruplex TaqMan qPCR for four porcine digestive pathogens, including B. hyodysenteriae [<a href="#ref-21">21</a>].
- Ren et al. (2024) reported a multiplex TaqMan qPCR that simultaneously detects porcine epidemic diarrhea virus, B. hyodysenteriae, and L. intracellularis [<a href="#ref-22">22</a>].
Oral fluid samples have emerged as a practical, non-invasive matrix for herd-level surveillance. Eddicks et al. (2025) demonstrated that multiplex qPCR on oral fluids provides adequate sensitivity for monitoring B. hyodysenteriae under field conditions, although fecal samples remain more sensitive for individual diagnosis [<a href="#ref-23">23</a>].
Long-read whole-genome sequencing (WGS) provides a rapid, culture-independent method for predicting AMR profiles directly from clinical samples, with accuracy exceeding 95% for known resistance determinants [<a href="#ref-24">24</a>].
flowchart TD
A["Compatible clinical signs: bloody mucoid diarrhea"] --> B{"Diagnostic sample type"}
B --> C["Fecal swab / fresh feces"]
B --> D["Oral fluid (herd-level)"]
B --> E["Colonic tissue (necropsy)"]
C --> F["Anaerobic culture on selective agar"]
C --> G["Multiplex qPCR (nox gene)"]
D --> G
E --> H["Histopathology + IHC"]
F --> I["Positive: β-hemolysis, indole+"]
G --> J["Positive: Ct < 35"]
H --> K["Confirms SD lesions"]
I & J & K --> L["Definitive diagnosis"]
J --> M["Negative or inconclusive"]
M --> N["Long-read WGS for AMR prediction"]
N --> LFigure 1. Diagnostic decision tree for swine dysentery. qPCR is the preferred initial test for both individual and herd-level diagnosis. Positive samples may be cultured for antimicrobial susceptibility testing (AST) or sequenced for genomic epidemiology.
Antimicrobial Susceptibility and Resistance
Therapeutic control historically relied on tiamulin, valnemulin, and carbadox. However, global surveillance reveals increasing minimum inhibitory concentrations (MICs) for pleuromutilins and macrolides [<a href="#ref-25">25</a>]. Hakimi et al. (2024) reported that approximately 15% of U.S. B. hyodysenteriae isolates were resistant to tiamulin, and resistance to lincomycin exceeded 30% [<a href="#ref-25">25</a>]. In northern Italy, De Lorenzi et al. (2024) found that 12% of isolates collected between 2005 and 2022 were multidrug-resistant (MDR) to three or more antimicrobial classes [<a href="#ref-26">26</a>].
Gentamicin has shown good in vitro activity against Spanish field isolates, with MIC₉₀ values below 2 µg/mL, but its in vivo efficacy remains under investigation [<a href="#ref-27">27</a>]. Medium-chain fatty acids, such as caprylic and capric acid, exhibit a dual antimicrobial effect, disrupting bacterial membranes and potentiating the action of pleuromutilins against MDR strains. A curcumin-derived metalloprotease inhibitor (CMC2.24) has been shown to reduce Brachyspira spp.-induced colitis severity by inhibiting the bacterial protease that degrades host mucin [<a href="#ref-28">28</a>].
The EFSA Panel on Animal Health and Welfare has categorized AMR B. hyodysenteriae as a moderate-risk priority for surveillance under EU Animal Health Law, emphasizing the need for prudent antimicrobial use and alternative control strategies [<a href="#ref-29">29</a>].
Control, Eradication, and Alternative Strategies
Eradication Approaches
Swine dysentery can be eradicated from infected herds using either a partial depopulation approach (remove affected groups, clean, disinfect, restock) or a management-based protocol combined with antimicrobials. Vangroenweghe (2025) successfully eradicated B. hyodysenteriae from an endemically infected herd using a protocol that combined a zinc chelate product with strict biosecurity measures, all-in/all-out management, and rodent control [<a href="#ref-4">4</a>]. Farmer motivation and satisfaction are critical for sustained eradication; Vidondo et al. (2022) identified financial incentives and technical support as key drivers for owners choosing to undertake eradication programs [<a href="#ref-30">30</a>].
Competitive Exclusion and Probiotics
Given the rise of AMR, non-antibiotic strategies are urgently needed. In vitro screening has identified commensal Lactobacillus and Bifidobacterium strains that inhibit B. hyodysenteriae growth through production of organic acids and bacteriocins [<a href="#ref-5">5</a>]. Gómez-Martínez et al. (2026) demonstrated that a competitive exclusion candidate (a Limosilactobacillus reuteri strain) significantly reduced B. hyodysenteriae adhesion to porcine intestinal epithelial cells [<a href="#ref-5">5</a>]. Other non-antibiotic components, such as medium-chain fatty acids and plant extracts, have shown moderate efficacy in reducing intestinal lesions caused by B. hyodysenteriae in co-culture intestinal models [<a href="#ref-31">31</a>].
Experimental Models
Reproducing swine dysentery in experimental settings is challenging. Parra-Aguirre et al. (2023) evaluated different inoculation strategies and found that oral gavage with feed withdrawal (24 h) and repeated inoculations (3 consecutive days) produced the most consistent disease [<a href="#ref-32">32</a>]. A seeder-pig model (direct contact with infected pigs) better mimics natural transmission and is recommended for vaccine challenge studies [<a href="#ref-33">33</a>]. Asymptomatic carriers (e.g., ST245 isolates) can be used to study subclinical shedding and within-herd transmission dynamics [<a href="#ref-9">9</a>].
Bioinformatics and Systems Biology
Whole-genome sequencing combined with long-read technology has enabled high-resolution population genomics. Vereecke et al. (2023) established that long-read WGS predicts MDR profiles with >95% sensitivity for known AMR determinants, offering a same-day diagnostic alternative to culture [<a href="#ref-24">24</a>]. Genome-wide association studies (GWAS) have identified lineage-specific genes associated with virulence and host adaptation [<a href="#ref-10">10</a>]. Metabolomic and transcriptomic datasets (e.g., from acute infection models) are now being integrated into systems-level models of host, pathogen interaction, revealing key metabolic bottlenecks that could be targeted by novel therapeutics [<a href="#ref-1">1</a>, <a href="#ref-2">2</a>].
Frequently Asked Questions
What is the primary route of transmission for Brachyspira hyodysenteriae?
The primary route is fecal, oral transmission, facilitated by contaminated pens, feed, water, and mechanical vectors such as flies [<a href="#ref-12">12</a>].
How is swine dysentery definitively diagnosed?
Definitive diagnosis requires laboratory detection of B. hyodysenteriae by culture or qPCR from fecal samples or colonic tissue, supported by compatible histopathological findings [<a href="#ref-11">11</a>, <a href="#ref-20">20</a>].
Can oral fluid samples replace fecal samples for monitoring?
Oral fluid samples are suitable for herd-level monitoring by multiplex qPCR but have lower sensitivity than fecal samples for detecting individual carriers [<a href="#ref-23">23</a>].
What is the role of the gut microbiota in disease susceptibility?
Pre-existing reductions in beneficial Lactobacillus and Prevotella populations predispose pigs to B. hyodysenteriae colonization, and acute infection further disrupts microbial diversity [<a href="#ref-3">3</a>, <a href="#ref-7">7</a>].
Are there effective alternatives to antibiotics for control?
Yes, competitive exclusion probiotics, medium-chain fatty acids, and protease inhibitors have demonstrated efficacy in vitro or in experimental models [<a href="#ref-5">5</a>, <a href="#ref-28">28</a>].
Can swine dysentery be eradicated from a herd?
Yes, eradication is achievable through combined strategies involving antimicrobials (e.g., zinc chelate), enhanced biosecurity, and all-in/all-out management, as demonstrated by successful field trials [<a href="#ref-4">4</a>] and national programs such as Sweden's [<a href="#ref-14">14</a>].